02/11/2026
As first treatments for metabolic dysfunction-associated steatohepatitis ( ) enter clinical practice, demand for accurate and monitoring options grows. Two new studies led by 🇬🇧 Newcastle University, published in The Lancet and Nature Medicine, outline new ways for non-invasive testing.
Two international studies show non-invasive tests can accurately diagnose and measure liver disease severity, reducing the need for biopsy.